Bacterial Effectors: Learning on the Fly

  • Laurent Boyer
  • Nicholas Paquette
  • Neal Silverman
  • Lynda M. Stuart
Conference paper
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 710)


A common defining characteristic of pathogenic bacteria is the expression of a repertoire of effector molecules that have been named virulence factors. These bacterial factors include a ­variety of proteins, such as toxins that are internalized by receptors and translocate across endosomal membranes to reach the cytosol, as well as others that are introduced directly into the cell by means of bacterial secretory apparatuses. Given the importance of these effectors for understanding bacterial pathogenicity, significant effort has been made to dissect their molecular mechanisms of action and their respective roles during infection. Herein we will discuss how Drosophila have been used as a model system to study these important microbial effectors, and to understand their contribution to pathogenicity.


Yersinia Pestis Innate Immune Pathway Bacterial Effector Powerful Genetic Tool Bacterial Effector Protein 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



We thank Emmanuel Lemichez for critical reading of the manuscript. LMS is supported by startup funds from MGHfC, MGH ECOR and grants from NIH/NIAID. NS is supported by grants from the NIH/NIAID (AI060025 and AI074958) and from BWF. NP is supported by a grant from the NIH (U54 AI057159). LB is supported by a fellowship from the Ligue Nationale Contre le Cancer.


  1. Ahlund MK, Ryden P, Sjostedt A, Stoven S (2010) Directed screen of Francisella novicida virulence determinants using Drosophila melanogaster. Infect Immun 78:3118–3128PubMedCrossRefGoogle Scholar
  2. Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124:783–801PubMedCrossRefGoogle Scholar
  3. Aktories K, Schmidt G, Just I (2000) Rho GTPases as targets of bacterial protein toxins. Biol Chem 381:421–426PubMedCrossRefGoogle Scholar
  4. Avet-Rochex A, Bergeret E, Attree I, Meister M, Fauvarque MO (2005) Suppression of Drosophila cellular immunity by directed expression of the ExoS toxin GAP domain of Pseudomonas aeruginosa. Cell Microbiol 7:799–810PubMedCrossRefGoogle Scholar
  5. Bokoch GM (2005) Regulation, of innate immunity by Rho GTPases. Trends Cell Biol 15:163–171PubMedCrossRefGoogle Scholar
  6. Boquet P, Lemichez E (2003) Bacterial virulence factors targeting Rho GTPases: parasitism or symbiosis? Trends Cell Biol 13:238–246PubMedCrossRefGoogle Scholar
  7. Botham CM, Wandler AM, Guillemin K (2008) A transgenic Drosophila model demonstrates that the Helicobacter pylori CagA protein functions as a eukaryotic Gab adaptor. PLoS Pathog 4:e1000064PubMedCrossRefGoogle Scholar
  8. Bourzac KM, Guillemin K (2005) Helicobacter pylori-host cell interactions mediated by type IV secretion. Cell Microbiol 7:911–919PubMedCrossRefGoogle Scholar
  9. Boyer L et al (2004) Rac GTPase instructs nuclear factor-kappaB activation by conveying the SCF complex and IkBalpha to the ruffling membranes. Mol Biol Cell 15:1124–1133PubMedCrossRefGoogle Scholar
  10. Boyer et al (2011) Identification of a conserved mechanism of effector-triggered immunity mediated by IMD and Rip proteins. Immunity in pressPubMedCrossRefGoogle Scholar
  11. Brodsky IE, Medzhitov R (2009) Targeting of immune signalling networks by bacterial pathogens. Nat Cell Biol 11:521–526PubMedCrossRefGoogle Scholar
  12. Cherry S, Silverman N (2006) Host-pathogen interactions in drosophila: new tricks from an old friend. Nat Immunol 7:911–917PubMedCrossRefGoogle Scholar
  13. Clarkson JM, Charnley AK (1996) New insights into the mechanisms of fungal pathogenesis in insects. Trends Microbiol 4:197–203PubMedCrossRefGoogle Scholar
  14. Colinet D, Schmitz A, Depoix D, Crochard D, Poirie M (2007) Convergent use of RhoGAP toxins by eukaryotic parasites and bacterial pathogens. PLoS Pathog 3:e203PubMedCrossRefGoogle Scholar
  15. Cornelis GR (2002) Yersinia, type III secretion: send in the effectors. J Cell Biol 158:401–408PubMedCrossRefGoogle Scholar
  16. Etienne-Manneville S, Hall A (2002) Rho GTPases in cell biology. Nature 420:629–635PubMedCrossRefGoogle Scholar
  17. Finlay BB, McFadden G (2006) Anti-immunology: evasion of the host immune system by bacterial and viral pathogens. Cell 124:767–782PubMedCrossRefGoogle Scholar
  18. Flatau G et al (1997) Toxin-induced activation of the G protein p21 Rho by deamidation of glutamine. Nature 387:729–733PubMedCrossRefGoogle Scholar
  19. Gottar M et al (2006) Dual detection of fungal infections in Drosophila via recognition of glucans and sensing of virulence factors. Cell 127:1425–1437PubMedCrossRefGoogle Scholar
  20. Hacker J, Kaper JB (2000) Pathogenicity islands and the evolution of microbes. Annu Rev Microbiol 54:641–679PubMedCrossRefGoogle Scholar
  21. Hatakeyama M (2006) The role of Helicobacter pylori CagA in gastric carcinogenesis. Int J Hematol 84:301–308PubMedCrossRefGoogle Scholar
  22. Henkel JS, Baldwin MR, Barbieri JT (2010) Toxins from bacteria. EXS 100:1–29PubMedGoogle Scholar
  23. Hoffmann JA, Kafatos FC, Janeway CA, Ezekowitz RA (1999) Phylogenetic perspectives in innate immunity. Science 284:1313–1318PubMedCrossRefGoogle Scholar
  24. Janeway CA, Medzhitov R (2002) Innate immune recognition. Annu Rev Immunol 20:197–216PubMedCrossRefGoogle Scholar
  25. Jones JD, Dangl JL (2006) The plant immune system. Nature 444:323–329PubMedCrossRefGoogle Scholar
  26. Jones RM et al (2008) Salmonella AvrA coordinates suppression of host immune and apoptotic defenses via JNK pathway blockade. Cell Host Microbe 3:233–244PubMedCrossRefGoogle Scholar
  27. Kawai T, Akira S (2009) The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol 21(4):317–337PubMedCrossRefGoogle Scholar
  28. Lemaitre B, Hoffmann J (2007) The host defense of Drosophila melanogaster. Annu Rev Immunol 25:697–743PubMedCrossRefGoogle Scholar
  29. Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoffmann JA (1996) The dorsoventral regulatory gene cassette spatzle/toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86:973–983PubMedCrossRefGoogle Scholar
  30. Lemonnier M, Landraud L, Lemichez E (2007) Rho GTPase-activating bacterial toxins: from bacterial virulence regulation to eukaryotic cell biology. FEMS Microbiol Rev 31:515–534PubMedCrossRefGoogle Scholar
  31. Martinelli C, Reichhart JM (2005) Evolution and integration of innate immune systems from fruit flies to man: lessons and questions. J Endotoxin Res 11:243–248PubMedGoogle Scholar
  32. Mittal R, Peak-Chew SY, McMahon HT (2006) Acetylation of MEK2 and I kappa B kinase (IKK) activation loop residues by YopJ inhibits signaling. Proc Natl Acad Sci USA 103:18574–18579PubMedCrossRefGoogle Scholar
  33. Monack DM, Mecsas J, Ghori N, Falkow S (1997) Yersinia signals macrophages to undergo apoptosis and YopJ is necessary for this cell death. Proc Natl Acad Sci USA 94:10385–10390PubMedCrossRefGoogle Scholar
  34. Mukherjee S et al (2006) Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation. Science 312:1211–1214PubMedCrossRefGoogle Scholar
  35. Orth K et al (2000) Disruption of signaling by Yersinia effector YopJ, a ubiquitin-like protein protease. Science 290:1594–1597PubMedCrossRefGoogle Scholar
  36. Palmer LE, Hobbie S, Galan JE, Bliska JB (1998) YopJ of Yersinia pseudotuberculosis is required for the inhibition of macrophage TNF-alpha production and downregulation of the MAP kinases p38 and JNK. Mol Microbiol 27:953–965PubMedCrossRefGoogle Scholar
  37. Palmer LE, Pancetti AR, Greenberg S, Bliska JB (1999) YopJ of Yersnia spp. is sufficient to cause downregulation of multiple mitogen-activated protein kinases in eukaryotic cells. Infect Immun 67:708–716PubMedGoogle Scholar
  38. Ribet D, Cossart P (2010) Post-translational modifications in host cells during bacterial infection. FEBS Lett 584:2748–2758PubMedCrossRefGoogle Scholar
  39. Rothenbacher D, Brenner H (2003) Burden of Helicobacter pylori and H. pylori-related diseases in developed countries: recent developments and future implications. Microbes Infect 5:693–703PubMedCrossRefGoogle Scholar
  40. Schmidt G et al (1997) Gln 63 of Rho is deamidated by Escherichia coli cytotoxic necrotizing factor-1. Nature 387:725–729PubMedCrossRefGoogle Scholar
  41. Stebbins CE, Galan JE (2001) Structural mimicry in bacterial virulence. Nature 412:701–705PubMedCrossRefGoogle Scholar
  42. Stramer B, Wood W (2009) Inflammation and wound healing in Drosophila. Methods Mol Biol 571:137–149PubMedCrossRefGoogle Scholar
  43. Stramer B et al (2005) Live imaging of wound inflammation in Drosophila embryos reveals key roles for small GTPases during in vivo cell migration. J Cell Biol 168:567–573PubMedCrossRefGoogle Scholar
  44. Sweet CR, Conlon J, Golenbock DT, Goguen J, Silverman N (2007) YopJ targets TRAF proteins to inhibit TLR-mediated NF-kappaB, MAPK and IRF3 signal transduction. Cell Microbiol 9:2700–2715PubMedCrossRefGoogle Scholar
  45. Visvikis O, Maddugoda MP, Lemichez E (2010) Direct modifications of Rho proteins: deconstructing GTPase regulation. Biol Cell 102:377–389PubMedCrossRefGoogle Scholar
  46. Vlisidou I et al (2009) Drosophila embryos as model systems for monitoring bacterial infection in real time. PLoS Pathog 5:e1000518PubMedCrossRefGoogle Scholar
  47. Vonkavaara M, Telepnev MV, Ryden P, Sjostedt A, Stoven S (2008) Drosophila melanogaster as a model for elucidating the pathogenicity of Francisella tularensis. Cell Microbiol 10:1327–1338PubMedCrossRefGoogle Scholar
  48. Weber AN et al (2007) Role of the Spatzle Pro-domain in the generation of an active toll receptor ligand. J Biol Chem 282:13522–13531PubMedCrossRefGoogle Scholar
  49. Zhou H et al (2005) Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-kappa B activation. J Exp Med 202:1327–1332PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Laurent Boyer
    • 1
    • 2
  • Nicholas Paquette
    • 3
  • Neal Silverman
    • 4
  • Lynda M. Stuart
    • 3
  1. 1.INSERM, U895, Centre Méditerranéen de Médecine MoléculaireToxines Microbiennes dans la relation hôte pathogènesNiceFrance
  2. 2.Université de Nice-Sophia-Antipolis, UFR MédecineNiceFrance
  3. 3.Developmental ImmunologyMassachusetts General Hospital/Harvard Medical SchoolBostonUSA
  4. 4.Division of Infectious Disease, Department of MedicineUniversity of Massachusetts Medical SchoolWorcesterUSA

Personalised recommendations